Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Fundamental & Clinical Pharmacology|November 30, 2018
Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databasesXavier Humbert, Sophie Fedrizzi, Basile Chrétien, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 8, 2017
Nivolumab Causing a Polymyalgia Rheumatica in a Patient With a Squamous Non-Small Cell Lung CancerMarjorie Bernier, Cyril Guillaume, Nathalie Leon, et al.
Therapie|July 18, 2016
[Reporting of harms in clinical trials: Vigilant support to the investigator. A guideline of REVISE' Group]Henri Marfin, Sophie Fedrizzi, Sabrina Crépin, et al.
British Journal of Clinical Pharmacology|December 4, 2020
Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's diseaseBasile Chrétien, Jean-Pierre Jourdan, Audrey Davis, et al.
Human Vaccines & Immunotherapeutics|November 10, 2022
COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance databaseBasile Chrétien, Rhéda Stroiazzo, Leila Troussier, et al.
Therapie|September 25, 2017
[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database]Xavier Humbert, Charles Dolladille, Marion Sassier, et al.
Current Pharmaceutical Design|January 13, 2021
Impact of Sex on Office White Coat effect Tail: A ReviewXavier Humbert, Sophie Fedrizzi, Agnès Hofferer, et al.
Therapie|November 29, 2018
Association between venous thromboembolism events and fibrates: A comparative studyCharles Dolladille, Xavier Humbert, Murielle Faucon, et al.
Expert Opinion on Drug Safety|July 19, 2019
Comparative study of hypoglycaemia induced by opioids. Is it a class effect?Basile Chrétien, Charles Dolladille, Léa Hamel-Sénécal, et al.
Pageof 5